Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1033 in NSTEMI Without Early Revascularization
NCT02146664Phase 3Withdrawn
- Sponsor
- Dexa Medica
- Start
- Nov 2015
- Primary completion
- Nov 2017
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS1033 in non-ST-elevation myocardial infarction (NSTEMI), sponsored by Dexa Medica. Planned start Nov 2015; status: withdrawn.
02
Drugs
DLBS1033
03
Conditions
non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT02146664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02146664.